BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 10736625)

  • 1. Stilbenes and bibenzyls with potential anticancer or chemopreventive activity.
    Orsini F; Verotta L
    Adv Exp Med Biol; 1999; 472():169-86. PubMed ID: 10736625
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmaceutical design of antimitotic agents based on combretastatins.
    Hsieh HP; Liou JP; Mahindroo N
    Curr Pharm Des; 2005; 11(13):1655-77. PubMed ID: 15892667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resveratrol and cancer prevention.
    Cheson BD
    Clin Adv Hematol Oncol; 2009 Mar; 7(3):142. PubMed ID: 19402261
    [No Abstract]   [Full Text] [Related]  

  • 4. Isolation and structure of the strong cell growth and tubulin inhibitor combretastatin A-4.
    Pettit GR; Singh SB; Hamel E; Lin CM; Alberts DS; Garcia-Kendall D
    Experientia; 1989 Feb; 45(2):209-11. PubMed ID: 2920809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resveratrol: a review of preclinical studies for human cancer prevention.
    Athar M; Back JH; Tang X; Kim KH; Kopelovich L; Bickers DR; Kim AL
    Toxicol Appl Pharmacol; 2007 Nov; 224(3):274-83. PubMed ID: 17306316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Soybean" in a Haystack? pinpointing an anti-cancer effect.
    Gottlieb N
    J Natl Cancer Inst; 1999 Oct; 91(19):1610-2. PubMed ID: 10511585
    [No Abstract]   [Full Text] [Related]  

  • 7. A new approach to combretastatin D2.
    Cousin D; Mann J; Nieuwenhuyzen M; van den Berg H
    Org Biomol Chem; 2006 Jan; 4(1):54-62. PubMed ID: 16357997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The world of resveratrol.
    Soleas GJ; Diamandis EP; Goldberg DM
    Adv Exp Med Biol; 2001; 492():159-82. PubMed ID: 11480664
    [No Abstract]   [Full Text] [Related]  

  • 9. Cellular and Molecular Targets of Resveratrol on Lymphoma and Leukemia Cells.
    Frazzi R; Guardi M
    Molecules; 2017 May; 22(6):. PubMed ID: 28555002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel plant-derived anticarcinogens.
    Kosmeder JW; Pezzuto JM
    IARC Sci Publ; 2002; 156():343-7. PubMed ID: 12484202
    [No Abstract]   [Full Text] [Related]  

  • 11. Synthesis, structural characterisation and biological evaluation of fluorinated analogues of resveratrol.
    Moran BW; Anderson FP; Devery A; Cloonan S; Butler WE; Varughese S; Draper SM; Kenny PT
    Bioorg Med Chem; 2009 Jul; 17(13):4510-22. PubMed ID: 19481462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Couplings of benzylic halides mediated by titanocene chloride: synthesis of bibenzyl derivatives.
    Barrero AF; Herrador MM; del Moral JF; Arteaga P; Akssira M; El Hanbali F; Arteaga JF; Diéguez HR; Sánchez EM
    J Org Chem; 2007 Mar; 72(6):2251-4. PubMed ID: 17309310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular basis of chemoprevention by resveratrol: NF-kappaB and AP-1 as potential targets.
    Kundu JK; Surh YJ
    Mutat Res; 2004 Nov; 555(1-2):65-80. PubMed ID: 15476852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The virtues of grapes].
    Bonard EC
    Rev Med Suisse Romande; 1997 Apr; 117(4):357-8. PubMed ID: 9281037
    [No Abstract]   [Full Text] [Related]  

  • 15. Resveratrol and breast cancer chemoprevention: molecular mechanisms.
    Le Corre L; Chalabi N; Delort L; Bignon YJ; Bernard-Gallon DJ
    Mol Nutr Food Res; 2005 May; 49(5):462-71. PubMed ID: 15786518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and cytotoxic evaluation of combretafurans, potential scaffolds for dual-action antitumoral agents.
    Pirali T; Busacca S; Beltrami L; Imovilli D; Pagliai F; Miglio G; Massarotti A; Verotta L; Tron GC; Sorba G; Genazzani AA
    J Med Chem; 2006 Aug; 49(17):5372-6. PubMed ID: 16913727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A reappraisal of the potential chemopreventive and chemotherapeutic properties of resveratrol.
    Gusman J; Malonne H; Atassi G
    Carcinogenesis; 2001 Aug; 22(8):1111-7. PubMed ID: 11470738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New Agents in Clinical Oncology. 24 November 2006, London, UK.
    Martin S
    IDrugs; 2007 Feb; 10(2):99-101. PubMed ID: 17285459
    [No Abstract]   [Full Text] [Related]  

  • 19. Cancer: one step at a time.
    Mooney D
    Nature; 2005 Jul; 436(7050):468-9. PubMed ID: 16049458
    [No Abstract]   [Full Text] [Related]  

  • 20. Synthesis and biological activity of mustard derivatives of combretastatins.
    Coggiola B; Pagliai F; Allegrone G; Genazzani AA; Tron GC
    Bioorg Med Chem Lett; 2005 Aug; 15(15):3551-4. PubMed ID: 15963722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.